About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

COMPLETEDPhase 4

Adalimumab in JIA-associated Uveitis Stopping Trial

Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial

NCT03816397•Nisha Acharya

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

UveitisJIA

Interventions

Adalimumab

Placebo

Locations

21

United States

Locations (21)

University of California, Davis

Sacramento, California, United States

University of California, San Francisco

San Francisco, California, United States

University of Colorado Denver

Aurora, Colorado, United States

Colorado Retina Associates

Lakewood, Colorado, United States

University of Miami

Miami, Florida, United States

Children's Mercy Hospital

Kansas City, Missouri, United States

Key Dates

Start Date

March 15, 2020

Primary Completion Date

January 23, 2025

Completion Date

April 3, 2025

Last Updated

May 11, 2025

Related Studies

RECRUITINGPhase 1/2

A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

NCT07218770

Active Noninfectious Uveitis Affecting the Posterior Segment

RECRUITINGPhase 3

The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

NCT05486468

UveitisUveitis, Posterior+2 more

RECRUITINGPhase 2

Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis

NCT02706704

UveitisNon-Infectious Uveitis

Active Not RecruitingPhase 3

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

NCT06431373

Uveitis, PosteriorUveitis, Intermediate+1 more

Active Not RecruitingNA

Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles

NCT07262437

Uveitis Posterior Non-InfectiousInflammation Eye+2 more

Active Not Recruiting

Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore

NCT07176130

UveitisScleritis and Episcleritis+3 more

View all related studies

Sponsors

Lead Sponsor

Nisha Acharya

Collaborators

Children's Hospital of Philadelphia
Children's Hospital Medical Center, Cincinnati
Children's Mercy Hospital Kansas City
National Eye Institute (NEI)
Great Ormond Street Hospital for Children NHS Foundation Trust
University Hospitals Bristol and Weston NHS Foundation Trust
Alder Hey Children's NHS Foundation Trust
Newcastle-upon-Tyne Hospitals NHS Trust
Sheffield Children's NHS Foundation Trust
Cambridge University Hospitals NHS Foundation Trust
Royal Children's Hospital
Norfolk and Norwich University Hospitals NHS Foundation Trust
Vanderbilt University Medical Center
University of California, Davis
University of Texas at Austin
University of Miami
University Hospitals, Leicester
University of Utah
Colorado Retina Associates
Manchester University NHS Foundation Trust

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 11, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions